Abstract

Biallelic mutations in the ovarian tumor domain-containing 6B (OTUD6B) gene, coding for a deubiquitinating enzyme, were recently described to cause an intellectual disability syndrome characterized by seizures and dysmorphic features in six families worldwide. We here report on a 6-year-old Italian girl, presenting mild intellectual disability, speech and motor delay, and recurrent seizures, who came to our attention after being screened for genes responsible for Rubinstein–Taybi syndrome, Kabuki syndrome, and epilepsy. We hence submitted the proband’s DNA to whole-exome sequencing, disclosing two candidate heterozygous splicing mutations in the OTUD6B gene: c.324+1G>C and c.405+1G>A. Both variants are reported in the GnomAD database with a frequency lower than the 10−5 and affect the donor splicing site, of exons 2 and 3, respectively. Sanger sequencing confirmed the segregation of the variants in the family, showing that both parents are carriers of one mutation. RT-PCR experiments demonstrated that both variants affect OTUD6B splicing and lead to the production of aberrant transcripts, the major ones being, in both cases, the skipping of the upstream exon. Quantitative analysis performed by competitive-fluorescent RT-PCR on the patient RNA showed that the proband presents less than 1% of wild-type transcripts, further strengthening the causative role of these variants. This represents the first replication of the involvement of the OTUD6B gene in this syndrome and points to the appropriateness of screening OTUD6B in suspected Rubinstein–Taybi syndrome patients with negative results after the screening of the major genes.

Highlights

  • Biallelic mutations in the ovarian tumor domain-containing 6B (OTUD6B) (Ovarian tumor domain-containing 6B) gene were recently described to cause an intellectual disability syndrome characterized by seizures and dysmorphic features in six families worldwide (Santiago-Sim et al, 2017; Online Mendelian Inheritance in Men, OMIM, #617452)

  • Among the approximately 100 DUBs encoded in the human genome, the OTU family comprises at least 16 DUBs containing a complete catalytic triad, including OTUD6B (Xu et al, 2011; Mevissen et al, 2013)

  • The proband is a 6-year-old female, second-born of nonconsanguineous healthy parents. She was born by cesarean section delivery at 38 weeks of gestation, after a pregnancy complicated by intrauterine growth restriction (IUGR)

Read more

Summary

Introduction

Biallelic mutations in the OTUD6B (Ovarian tumor domain-containing 6B) gene were recently described to cause an intellectual disability syndrome characterized by seizures and dysmorphic features in six families worldwide (Santiago-Sim et al, 2017; Online Mendelian Inheritance in Men, OMIM, #617452). The OTUD6B gene (located on chromosome 8q21.3, 17 kb long) encodes a deubiquitinating enzyme (Sobol et al, 2017). Splicing Mutations in OTUD6B different biological processes, such as apoptosis, oncogenes, and tumor suppressor signaling, DNA replication and repair, and checkpoint regulation (Bhattacharya and Ghosh, 2014). Among the approximately 100 DUBs encoded in the human genome, the OTU (ovarian tumor) family comprises at least 16 DUBs containing a complete catalytic triad, including OTUD6B (Xu et al, 2011; Mevissen et al, 2013). In non-small cell lung cancer, the two main OTUD6B isoforms have been shown to have opposite effects on global protein synthesis and on DNA synthesis, with OTUD6B-1 stimulating protein and DNA synthesis and OTUD6B-2 repressing both processes (Sobol et al, 2017)

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call